NCT05723406View on ClinicalTrials.gov

The Immunomodulatory Effect of Sugammadex After Total Hip Replacement Surgery Under Neuraxial Anaesthesia: a Pilot Study

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 21, 2023

Primary Completion Date

November 23, 2023

Study Completion Date

November 23, 2023

Conditions
Innate Inflammatory ResponseOsteoarthritis, Hip
Interventions
DRUG

Sugammadex 100 MG/ML [Bridion]

8 mg/ml

OTHER

Placebo

Sodium 0.9% 5 ml

Trial Locations (1)

6500HB

Radboudumc, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER